FCGR3A and cancer: CD3+CD8+ cytotoxic T cells (CTLs) are the main lymphocytes directly fighting differentiated tumors, while CD16+++CD56+ cytotoxic natural killer (NK) cells and CD16+/‐CD56++ split‐anergized NK cells are the main immune cells targeting poorly differentiated tumors/cancer stem cells (CSCs).25